Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Applied Biological Materials/dCas9-KRAB Lentiviral Vector/10 µg/145.00188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Applied Biological Materials/dCas9-KRAB Lentiviral Vector/10 µg/145.00

Specifications
Specifications
Description

dCas9-KRAB is used for CRISPR gene repression (CRISPRi). The Cas9 Double Mutant (dCas9) has changes at amino acid positions D10A and H840A which completely inactivate both the nuclease and nickase activities. In this construct, dCas9 carries a C-terminal Krüppel associated box (KRAB) domain. By targeting dCas9-KRAB to a promoter region, users will be able to specifically repress expression of virtually any gene of interest. This dCas9-KRAB lentiviral vector may be used for either non-viral transfection, or packaged into lentivirus for stable integration of dCas9-KRAB into host cells. Use this dCas9-KRAB lentiviral vector in conjunction with a CRISPRi sgRNA lentiviral vector designed specifically for CRISPR repression.

SKUK203
SystemLentiviral Vector
Vector MappLenti-EF1a-dCas9-KRAB
Unit quantity10 µg
PromoterEF1a
Cas TypeNull Mutant
Cas OriginspCas9
Cas9 ExpressionConstitutive Cas9
Shipping Conditions

Shipped at ambient temperature

Bacterial SelectionKanamycin
FormatVector
AppearanceLiquid
Quality ControlRestriction Enzyme Digest and Sequencing
Shelf Life1 year (when at -20°C or below)
CautionThis product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information.
Documents
Documents
Supporting Protocol
    MSDS
      QC
        Other
          FAQs
          FAQs
          There are no FAQs for this product yet!
          References
          References
          1
          • Dai, X., Chen, X., Hakizimana, O., & Mei, Y. "Genetic interactions between ANLN and KDR are prognostic for breast cancer survival" Oncology Reports. : (2019).
          新闻动态
          行业前沿
          技术文章
          最新产品